USFDA APPLICATION NUMBER - 20711 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
BUPROPION HYDROCHLORIDE(UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) | BUPROPION HYDROCHLORIDE | 150mg |
Inactive Ingredients
Ingredient Name | GlaxoSmithKline LLC |
---|---|
CARNAUBA WAX(R12CBM0EIZ) | |
CYSTEINE HYDROCHLORIDE(ZT934N0X4W) | |
FD&C BLUE NO. 2(L06K8R7DQK) | |
FD&C RED NO. 40(WZB9127XOA) | |
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
MAGNESIUM STEARATE(70097M6I30) | |
MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
POLYSORBATE 80(6OZP39ZG8H) | |
TITANIUM DIOXIDE(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?